Novel Assay Methods for Cancer Patient-Derived Organoids

Poster Presented at SLAS2021 Virtual

Evan Cromwell, Ph.D

View Poster Synopsis in the Video below

Poster Synopsis

This poster was presented at SLAS2021. We demonstrated the use of the Pu·MA System 3D for assays using patient-derived organoids to efficiently:

  • treat the organoids with chemotherapeutic drugs 
  • high content imaging of organoids to study phenotypic response
  • followed by live/dead analysis

Featured News

Jul 9, 2020 Protein Fluidics' Organoid Research Award: Prof. Matthew E. Burow & team (Tulane Univ)
Jan 25, 2020
Protein Fluidics launches Pu·MA System 3D for automated organoid assays
December 4, 2018
Protein Fluidics partners with BioLegend to provide Assay Products

May 4, 2018 Protein Fluidics announces the Pu·MA system
October 1, 2016 Protein Fluidics moves into new headquarters in Burlingame, CA
April 6, 2016 Protein Fluidics closes Series seed round of investment

For Research Use Only. Not for diagnostic use. Protein Fluidics, Protein Fluidics Logo and Pu•MA System are registered trademarks of Protein Fluidics, Inc. in the United States and internationally. All rights reserved. © 2021 PROTEIN FLUIDICS, INC.